CEBINA’s drug repurposing project has led to the identification of commonly used drugs with activity against SARS-CoV-2 infection in in vitro assays.
CEBINA’s drug repurposing project has led to the identification of commonly used drugs with activity against SARS-CoV-2 infection in in vitro assays.